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1. Introduction 
Porcine and bovine PDH complexes are inactivated 
and phosphorylated with MgATP by a kinase intrinsic 
to the complex. Fully phosphorylated PDHP complex 
(+P&) contains 3 phosphorylated serine residues. 
These are recovered after tryptic digestion in a tetra- 
decapeptide (site 1, Ser 5; site 2, Ser 12) and a 
nonapeptide (site 3, Ser 6) of known amino acid 
sequence [ 1,2]. Discontinuous phosphorylation by 
incremental additions of a limiting amount of ATP 
leads to selective phosphorylation of site 1 yielding 
PDHPcomplex (CUP .a/3,) [ 1,3], This and other 
methods [2,4] have shown that inactivation is corre- 
lated with phosphorylation of site 1. Phosphorylation 
of sites 2 and 3 inhibits reactivation of the complex 
by PDHP phosphatase [S ,6]. Investigation of the 
physiological significance of site 2 and site 3 
phosphorylations would be facilitated if one or more 
sites of phosphorylation could be blocked by groups 
which are resistant to attack by PDHP phosphatase. 
Conversion of phosphorylase b to phosphorylase a 
with phosphorylase kinase has been accomplished 
with ATPyS. The resultant (presumed) thiophos- 
phoryl phosphorylase is resistant to a-b conversion 
by phosphorylase phosphatase [7]. We describe here 
inactivation of pig heart PDH complex by ATPyS, 
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give evidence that this involves thiophosphorylation 
of the complex and that inactive PDH(SP) complex is 
resistant to reactivation by PDHP phosphatase. 
2. Experimental 
2.1 Materials 
ATPyS was from BCL, Lewes, Sussex. Manu- 
facturers analysis showed 12% ADP; this was con- 
firmed by ion-exchange thin-layer chromatography 
on PEl-cellulose [8] which also showed no more than 
a trace of ATP. Sources of other biochemicals, radio- 
chemicals, PDH complex and ox heart PDHP 
phosphatase are given in [3,6,9]. 
PDHP complex (CUP .~$3~) was prepared by discon- 
tinuous phosphorylation [S] in 20 mM potassium 
phosphate/2 mM DTT/ 0.2 mM MgClz (pH 7) with 
[y-32P]ATP (110 dpm/pmol). PDH(SP) complex was 
prepared by exactly the same method substituting 
ATPyS for ATP. The complexes were recovered by 
centrifugation through 4 vol. 2% (w/v) sucrose in 
phosphate/DTT [9] (90 min, 4”C, IS0 000 X g) and 
taken up in phosphate/DTT; or dialysed for 60 h at 
4’C against 4 changes of 100 vol. phosphate/DTT. 
Recovery of PDHP complex (based on protein-bound 
32P) was >9S%; it is assumed that the recovery of 
PDH(SP) complex was the same. Based on this 
recovery preparations of PDHP and PDH(SP) com- 
plexes contained <S% of active complex. Incorpora- 
tion of 32P was 0.45-0.51 nmol/unit PDH complex 
inactivated. 
For conversion to [cu2P . (SP),P2], PDHP complex 
(aP . c&J was incubated for 60-90 min at 30°C with 
0.42-0.5 mM ATPyS/l mM MgClz. Evidence for this 
conversion is given in section 3 .l . During incubation 
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with ATPyS, loss of protein-bound 32P (5% in 
60 min) suggested that if exchange of protein-bound 
32P with the thiophosphoryl group of ATPyS occurs, 
it is slow. The thiophosphoryl PDHP complex was 
dialysed for 60 h at 4°C (4 X 100 vol. phosphate/ 
DTT with 1 mM EDTA in the first 3). Conversion of 
PDH(SP) complex to [cy*(SP) . (P)2p2] was effected 
by incubation for 60 min at 30°C with 0.5 mM 
[Y-~~P] ATP (176 dpm/pmol) and 1 mM MgC12. 
Incorporation of 32P was 0.64 nmoljunit PDH com- 
plex thiophosphorylated. 
The ATPase activity of PDH complexes hydrolysed 
<1% of ATP/min under conditions of fig.1. 
2.2.Met/zods 
PDH complex was assayed spectophotometrically 
by NADH formation [lo] (I unit is 1 pmol NADI-I 
formed/min), ATP and ATPyS were assayed spectro- 
photometrically in 1 M HCl at 257 nm. Protein- 
bound 32P was assayed as in [.5]. Incorporation of 
32P into sites I --3 in PDHP complexes was assayed 
after tryptic digestion and high-voltage paper electro- 
phoresis 131. Incorporation of 14C from [ 1 -*?J acetyl 
CoA into lipoyl residues in PDHP and PDH(SP) com- 
plexes was determined as in [9]. Acetyl CoA solu- 
tions were standardised spectrophotometrically [3]. 
32P was assayed in PDH 32P complexes after trichloro- 
aceiic acid precipitation (10% w/v) in the presence of 
bovine serum albumin [lo]. ATPase activity was 
measured by 32Pi release from [y-32P]ATP [ 101. 
Release of active PDH complex and of 32Pi from 
(aP . ~$3~) [oc(SP)@3,] and [azP(SP),f12] with PDHP 
phosphatase was assayed following incubation in 
10 mM potassium phosphate/25 mM Tris-HC1/2 mM 
DTT/ 10 mM EGTA/9.75 mM CaC12/25 mM MgCI, 
(pH 7) (medium A). 
3. Results and discussion 
Indirect methods were necessary to demonstrate 
thiophospho~lation of PDH complex by ATPyS 
because it has not been possible to prepare [3”S]- 
ATPyS. We have prepared sodium thiophosphate, 
[35S]thiophosphate and acetyl thiophosphate by 
established methods. The synthesis of sodium thio- 
phosphate was ~on~rmed by 31P NMR which showed 
also that contamination with sodium phosphate was 
<2%. It has not been possible to prepare [35S]ATPyS 
in sufficient yield or of utilisable specific activity by 
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employing methods of exchange [ 11,121 or net syn- 
thesis based on triose phosphate dehydrogenase + 
diphosphoglycerate kinase or acetate kinase [ 131. 
3 .l . Thiophosphoiylatiorz of pig heart PLIH complex 
Figure 1 shows that pig heart PDH complex is 
inactivated by incubation with ATP@. Panel (a) in 
fig.1 shows that the rate of inactivation with ATPyS 
is slower than with ATP at equivalent concentrations 
(0.5 mM). Apparent Km values were (mean + SEM) 
6.26 rl: 2.36pM MgATPand 6.32 + 1.671.1M gATPyS 
(3 obs. each at 11,24,55 and 201 PM MgATP; and 
9,2 1,48 and I76 FM ATP$). The values for V,,,, 
(mean rt SEM in % of complex inactivated in 1 min) 
were 50.4 + 3.46% (ATP) and 34.6 + 1 .X1% (ATPyS) 
(P for difference <O.OOl). The difference in rates of 
inactivation in fig.I(a) thus appears to be the result 
of differences in V,,-. It should be noted that 
ATPrS contained 12% of ADP (a competitive 
inhibitor of the PDH kinase reaction) whereas ATP 
contained only 0.5% of ADP (manufacturers analysis). 
However the Ki for ADP is much higher than the Km 
for MgATP and MgATPrS and the presence of 12% 
of ADP should only reduce the calculated V,, by 
6% (assuming Ki for ADP with ATPyS is the same as 
with ATP). There is evidence that ATPrS can form 
“:I, yy$___ Y$._ 
1 I J 
0 5 
mmutes 
10 0 
‘minutes lo 
Fig.1. incubations made at 30°C in (a) phosphate/DTT 
(1 mM MgCl,) with 0.5 mM ATP (A) or 0.5 mM ATP$ (A) 
and in (b) only, 1 mM NAD’. After 5 min pre~cubation, 
reaction initiated with PDH complex (to 2.26 units/ml) and 
samples for assay of PDH complex taken at times shown. 
Points are means of 2 obs. 
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disulphideswith protein-SH groups [ 141 and it seemed 
important to exclude the possibility of disulphide 
formation with the lipoyl moieties of the PDH com- 
plex and consequent inactivation. As shown in 
fig.l(b), NAD’ (which oxidises lipoyl residues in the 
complex) had no effect on inactivation of PDH com- 
plex by ATP-/S. Rates with ATP and with ATPyS 
were slower in the presence of NAD’ as expected [3]. 
The integrity of lipoyl residues was shown directly 
by acetylation with [ l-14C]acetyl CoA in the pres- 
ence of NADH. Incorporations (mean f SEM for 
6,obs. in nmol acetyl/unit PDH complex equiv.) were 
0.77 + 0.01 (PDHP complex) and 0.76 + 0.01 
[PDH(SP) complex]. It is known that phosphoryla- 
tion of the PDH complex does not inhibit the dihydro- 
lipoate acetyltransferase or lipoyldehydrogenase reac- 
tions [9]; our findings show that thiophosphorylation 
does not inhibit these reactions. 
Indirect evidence for thiophosphorylation of each 
of the 3 sites of phosphorylation in the PDH complex 
may be summarised as follows. PDH32P complex 
(oP . ~$3~) prepared by the discontinuous method of 
phosphorylation shows 86-9 1% of 32P in site 1, 
9-12% of 32P in site 2 and O-2% of 32P in site 3 
[ 1,3,6]. PDHP complex (CWP . ap2) prepared with non- 
radioactive ATP, incorporates 32P from [Y-~“P] ATP 
into sites 2 and 3 [3]. PDH(SP) complex [(Y(SP)~L] 
incorporated 32P into sites 2 and 3 in strictly analo- 
gous fashion. This was shown by the presence of 32P 
in two phosphopeptides whose electrophoretic 
mobilities corresponded to the diphosphotetradeca- 
peptide (sites 1 and 2) and to the phosphononapeptide 
(site 3) [ 1,3]. This indicates thiophosphorylation of 
site 1. When PDH32P complex (crP .a&) was 
incubated with ATPyS, 32P moved from the phospho- 
tetradecapeptide to the diphosphotetradecapeptide 
on high-voltage electrophoresis. This indicates thio- 
phosphorylation of site 2 which has also been shown 
in [ 151. The phosphorylation of site 3 was assumed 
from the following. PDH32P complex (0rP . ~43~) was 
prepared with low specific activity [y-32P]ATP 
(4 dpm/pmol) and contained 0.5 1 nmol P/unit com- 
plex inactivated. It was then incubated for 90 min 
with 0.5 mM ATPyS (see section 2.1). The presumed 
PDHP(SP):, complex (recovered by centrifugation) 
was then incubated with high specific activity 
[-r-32~]~~P(180d / pm pmol) in an attempt to identify 
vacant phosphorylation sites, The incorporation 
(0.09 nmol P/unit PDH complex) was GO% of the 
incorporation of 32P into sites 2 and 3 of PDHP (oP .@z). 
It is assumed therefore that sites 2 and 3 were thio- 
phosphorylated. 
3.2. Effect of PDHPphosphatase on thiophospholyl 
complexes 
Figure 2 shows that there was very little reactiva- 
tion of PDH(SP) complex [a(SP)&] by ox-heart 
PDHP phosphatase. Reactivation over 30 min at high 
phosphatase only achieved 7% of the reactivation of 
PDHP complex (CWP . a&) achieved in 5 min under 
identical conditions (shown in fig.2). In further 
experiments it was shown that PDH(SP) complex 
[o(SP)of12] is a competitive inhibitor of the release of 
32P from PDH32P complex (cY.P . c&) with ox-heart 
ph&phatase. The Km for PDHP was 15.9 f 0.88 
units/ml (PDH complex equiv.) and the Ki for 
PDH(SP) was 32.7 f 1.53 units/ml (mean + SEM; 
5 cont. PDHP over 6.4-34.9 units/ml; PDH(SP) 
34.9 units/ml; 8 obs. each cont.; measurements at 
2.5 min, maximum hydrolysis 37%). 
Figure 3 shows that ox-heart PDHP phosphatase 
released as 32Pi, 86% of the 32P in PDH32P (SP), com- 
plex. This release of 32P was associated with conver- i 
sion of 12% of the inactive PDHP(SP)2 complex to 
active complex. Release of 32Pi was 4.36 + 0.27 nmol 
P/unit active complex formed (I, 0.985). This may be 
compared with the release of 0.41 nmol P/unit active 
Fig.2. Incubations were made at 30°C in medium A (see 
section 2.2) (16 mM Mg*, 13 PM Cati) with either PDHP 
complex (*,A) or PDH(SP) complex (~,a) (9 units/ml). After 
5 min preincubation, reaction initiated with 5 ~1 (~,b) or 
20 ~1 (o,o) of ox heart phosphatase. Samples taken for assay 
of PDH complex at times shown. Each point is mean of 3 obs. 
corrected for zero time PDH complex activity [ 3.5% in 
PDHP; 3.1% in PDH(SP)]. At all times P < 0.001 for dif- 
ferences [(A)-(A)] and [(o)-(o)]. 
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Fig.3. Incubations made at 30°C in medium A (see section 
2.2) (f6 mM Mg**, 13 pM Ca**) and 4.95 units PDH3*P(SF& 
complex. After 5 min preincubation reactzon initiated witk 
20 ~1 ox-heart PDHP phosphatase. Samples taken for assay of 
PDH complex (A) or JzPi (.I), at times shown. Total 32P in the 
incubate was estimated at 30.5 min. The values for ““pi were 
corrected for 3”Pi n the PDH”P(SP), complex (0.21% of 
total). The complex was devoid of PDH complex activity. At 
the Iimit 12% of complex was reactivated and 86% of 32P 
released as ““Pi. Points are means of 3 obs. 
complex formed from PDHP complex (olP - Cup-J [S’j. 
The experiment was repeated (not shown in fig.3); 
17% of complex was reactivated and release of 32Pj was 
3.91 nmof P/unit. Three interpretations are possible 
and these cannot readily be d~stin~uisbed with 
techniques at present available. 
PDH(SP)i complex (i.e., PDH complex thio- 
phosphorylated in sites 2 and 3) is active but. has 
12-17% of the activity of PDH complex. 
PDHP complex (0lP . ~$3~) contains 9- 12% of 
phosphate in site 2 and PDIYIP(SP)~ complex may 
therefore contain up to 12% of phosphate in 
site 2. If site 3 was in~o~lplete~y thiophos- 
phoryiat~d, some reactivation could occur by 
removal of phosphate. 
It is possible that PDHP phosphatase may remove 
thjophosp~late from sites 2 and 3. 
Little or no reactivation of bovine kidney 
PDHP(SP), complex on removal of phosphate with 
bovine kidney phosphatase was observed [ 15). The 
reason for the discrepancy between oar findings and 
those in [ 151 is not apparent. The t~~hn~q~e of selec- 
tive phnsphorylation of site 1 in [ 1 S] was less selective 
than the technique of discontinuous phosphorylation 
used here (25% of the 32P incorporated in PDHP(SP), 
in [I 51 was in sites 2 and 3). It was concluded in 
1 X5] that sites 2 and 3 may be inactivating sites. 
Evidence given in {4] has shown that site 3 plays no 
part in illactivation in viva and that sites 2 and 3 
inhibit reactivation by PDHP phosphatase [5,6]. 
We thank Dr D. C. Gadian of the Department of 
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